Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (TSX:CRDL)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Cardiol Therapeutics Charts.
Cardiol Therapeutics (TSX:CRDL)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Cardiol Therapeutics Charts.